Renaissance Technologies »

Apimeds Pharmaceuticals Us I shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $50k 28k 1.78

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Kinross Gold Corp (KGC)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Doordash Cl A (DASH)
Hims & Hers Health Com Cl A (HIMS)
Reddit Cl A (RDDT)

View all positions for Renaissance Technologies

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Renaissance Technologies
XTX Topco
Hrt Financial
Jpmorgan Chase & Co

View all funds holding Apimeds Pharmaceuticals Us I